nodes	percent_of_prediction	percent_of_DWPC	metapath
Paliperidone—Atrial fibrillation—Mesalazine—Crohn's disease	0.00304	0.00506	CcSEcCtD
Paliperidone—Thirst—Mesalazine—Crohn's disease	0.00302	0.00504	CcSEcCtD
Paliperidone—Suicidal ideation—Prednisone—Crohn's disease	0.00299	0.00498	CcSEcCtD
Paliperidone—Anaemia—Mercaptopurine—Crohn's disease	0.00295	0.00492	CcSEcCtD
Paliperidone—Lethargy—Mesalazine—Crohn's disease	0.00294	0.00489	CcSEcCtD
Paliperidone—Mania—Prednisone—Crohn's disease	0.00289	0.0048	CcSEcCtD
Paliperidone—Osteoarthritis—Mesalazine—Crohn's disease	0.00288	0.00479	CcSEcCtD
Paliperidone—Leukopenia—Mercaptopurine—Crohn's disease	0.00286	0.00476	CcSEcCtD
Paliperidone—Disturbance in sexual arousal—Mesalazine—Crohn's disease	0.00286	0.00476	CcSEcCtD
Paliperidone—Glaucoma—Prednisone—Crohn's disease	0.00279	0.00464	CcSEcCtD
Paliperidone—Face oedema—Mesalazine—Crohn's disease	0.00278	0.00463	CcSEcCtD
Paliperidone—Arthralgia—Mercaptopurine—Crohn's disease	0.00272	0.00453	CcSEcCtD
Paliperidone—Unspecified disorder of skin and subcutaneous tissue—Mercaptopurine—Crohn's disease	0.0027	0.0045	CcSEcCtD
Paliperidone—Pancreatitis—Azathioprine—Crohn's disease	0.00268	0.00446	CcSEcCtD
Paliperidone—Dry skin—Mesalazine—Crohn's disease	0.00264	0.00439	CcSEcCtD
Paliperidone—Orthostatic hypotension—Mesalazine—Crohn's disease	0.00263	0.00438	CcSEcCtD
Paliperidone—Abdominal pain upper—Mesalazine—Crohn's disease	0.00263	0.00438	CcSEcCtD
Paliperidone—Abdominal discomfort—Azathioprine—Crohn's disease	0.00262	0.00436	CcSEcCtD
Paliperidone—Oedema—Mercaptopurine—Crohn's disease	0.00261	0.00434	CcSEcCtD
Paliperidone—Breast disorder—Mesalazine—Crohn's disease	0.0026	0.00433	CcSEcCtD
Paliperidone—Aspartate aminotransferase increased—Mesalazine—Crohn's disease	0.00259	0.00432	CcSEcCtD
Paliperidone—Glycosuria—Prednisone—Crohn's disease	0.00259	0.00431	CcSEcCtD
Paliperidone—Nasopharyngitis—Mesalazine—Crohn's disease	0.00257	0.00429	CcSEcCtD
Paliperidone—Thrombocytopenia—Mercaptopurine—Crohn's disease	0.00255	0.00425	CcSEcCtD
Paliperidone—Alanine aminotransferase increased—Mesalazine—Crohn's disease	0.00254	0.00423	CcSEcCtD
Paliperidone—Skin disorder—Mercaptopurine—Crohn's disease	0.00253	0.00422	CcSEcCtD
Paliperidone—Endocrine disorder—Prednisone—Crohn's disease	0.00253	0.00422	CcSEcCtD
Paliperidone—Acne—Prednisone—Crohn's disease	0.00249	0.00415	CcSEcCtD
Paliperidone—Dysphagia—Mesalazine—Crohn's disease	0.00249	0.00414	CcSEcCtD
Paliperidone—Influenza—Mesalazine—Crohn's disease	0.00249	0.00414	CcSEcCtD
Paliperidone—Anorexia—Mercaptopurine—Crohn's disease	0.00248	0.00414	CcSEcCtD
Paliperidone—Pneumonia—Azathioprine—Crohn's disease	0.00245	0.00408	CcSEcCtD
Paliperidone—Pancreatitis—Mesalazine—Crohn's disease	0.00244	0.00406	CcSEcCtD
Paliperidone—Infestation NOS—Azathioprine—Crohn's disease	0.00244	0.00406	CcSEcCtD
Paliperidone—Infestation—Azathioprine—Crohn's disease	0.00244	0.00406	CcSEcCtD
Paliperidone—Bronchitis—Mesalazine—Crohn's disease	0.00239	0.00398	CcSEcCtD
Paliperidone—Amenorrhoea—Prednisone—Crohn's disease	0.00239	0.00398	CcSEcCtD
Paliperidone—Abdominal discomfort—Mesalazine—Crohn's disease	0.00239	0.00397	CcSEcCtD
Paliperidone—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.00238	0.00396	CcSEcCtD
Paliperidone—Dysuria—Mesalazine—Crohn's disease	0.00233	0.00387	CcSEcCtD
Paliperidone—Neutropenia—Mesalazine—Crohn's disease	0.00233	0.00387	CcSEcCtD
Paliperidone—Viral infection—Prednisone—Crohn's disease	0.00232	0.00387	CcSEcCtD
Paliperidone—Upper respiratory tract infection—Mesalazine—Crohn's disease	0.00231	0.00385	CcSEcCtD
Paliperidone—Hepatobiliary disease—Azathioprine—Crohn's disease	0.0023	0.00384	CcSEcCtD
Paliperidone—Pollakiuria—Mesalazine—Crohn's disease	0.0023	0.00383	CcSEcCtD
Paliperidone—Agranulocytosis—Azathioprine—Crohn's disease	0.00227	0.00379	CcSEcCtD
Paliperidone—Decreased appetite—Mercaptopurine—Crohn's disease	0.00227	0.00377	CcSEcCtD
Paliperidone—Weight increased—Mesalazine—Crohn's disease	0.00226	0.00377	CcSEcCtD
Paliperidone—Weight decreased—Mesalazine—Crohn's disease	0.00225	0.00375	CcSEcCtD
Paliperidone—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.00225	0.00375	CcSEcCtD
Paliperidone—Pneumonia—Mesalazine—Crohn's disease	0.00223	0.00372	CcSEcCtD
Paliperidone—Infestation NOS—Mesalazine—Crohn's disease	0.00222	0.00369	CcSEcCtD
Paliperidone—Infestation—Mesalazine—Crohn's disease	0.00222	0.00369	CcSEcCtD
Paliperidone—Depression—Mesalazine—Crohn's disease	0.00221	0.00368	CcSEcCtD
Paliperidone—Jaundice—Mesalazine—Crohn's disease	0.00216	0.0036	CcSEcCtD
Paliperidone—Conjunctivitis—Mesalazine—Crohn's disease	0.00216	0.00359	CcSEcCtD
Paliperidone—Urinary tract infection—Mesalazine—Crohn's disease	0.00216	0.00359	CcSEcCtD
Paliperidone—Hepatobiliary disease—Mesalazine—Crohn's disease	0.0021	0.00349	CcSEcCtD
Paliperidone—Epistaxis—Mesalazine—Crohn's disease	0.00209	0.00348	CcSEcCtD
Paliperidone—Sinusitis—Mesalazine—Crohn's disease	0.00208	0.00347	CcSEcCtD
Paliperidone—Agranulocytosis—Mesalazine—Crohn's disease	0.00207	0.00345	CcSEcCtD
Paliperidone—Body temperature increased—Mercaptopurine—Crohn's disease	0.00206	0.00343	CcSEcCtD
Paliperidone—Rhinitis—Mesalazine—Crohn's disease	0.002	0.00333	CcSEcCtD
Paliperidone—Fluid retention—Prednisone—Crohn's disease	0.00199	0.00332	CcSEcCtD
Paliperidone—Immune system disorder—Azathioprine—Crohn's disease	0.00197	0.00329	CcSEcCtD
Paliperidone—Mediastinal disorder—Azathioprine—Crohn's disease	0.00197	0.00328	CcSEcCtD
Paliperidone—Urinary tract disorder—Mesalazine—Crohn's disease	0.00197	0.00328	CcSEcCtD
Paliperidone—Oedema peripheral—Mesalazine—Crohn's disease	0.00196	0.00327	CcSEcCtD
Paliperidone—Chills—Azathioprine—Crohn's disease	0.00196	0.00327	CcSEcCtD
Paliperidone—Connective tissue disorder—Mesalazine—Crohn's disease	0.00196	0.00326	CcSEcCtD
Paliperidone—Urethral disorder—Mesalazine—Crohn's disease	0.00195	0.00325	CcSEcCtD
Paliperidone—Alopecia—Azathioprine—Crohn's disease	0.00193	0.00322	CcSEcCtD
Paliperidone—Hypersensitivity—Mercaptopurine—Crohn's disease	0.00192	0.0032	CcSEcCtD
Paliperidone—Eye disorder—Mesalazine—Crohn's disease	0.00186	0.0031	CcSEcCtD
Paliperidone—Tinnitus—Mesalazine—Crohn's disease	0.00186	0.00309	CcSEcCtD
Paliperidone—Cardiac disorder—Mesalazine—Crohn's disease	0.00185	0.00308	CcSEcCtD
Paliperidone—Hyperkinesia—Prednisone—Crohn's disease	0.00183	0.00305	CcSEcCtD
Paliperidone—Angiopathy—Mesalazine—Crohn's disease	0.00181	0.00301	CcSEcCtD
Paliperidone—Immune system disorder—Mesalazine—Crohn's disease	0.0018	0.003	CcSEcCtD
Paliperidone—Mediastinal disorder—Mesalazine—Crohn's disease	0.00179	0.00299	CcSEcCtD
Paliperidone—Chills—Mesalazine—Crohn's disease	0.00179	0.00298	CcSEcCtD
Paliperidone—Diarrhoea—Mercaptopurine—Crohn's disease	0.00178	0.00297	CcSEcCtD
Paliperidone—Ill-defined disorder—Azathioprine—Crohn's disease	0.00177	0.00294	CcSEcCtD
Paliperidone—Alopecia—Mesalazine—Crohn's disease	0.00176	0.00293	CcSEcCtD
Paliperidone—Anaemia—Azathioprine—Crohn's disease	0.00176	0.00293	CcSEcCtD
Paliperidone—Diabetes mellitus—Prednisone—Crohn's disease	0.00175	0.00292	CcSEcCtD
Paliperidone—Mental disorder—Mesalazine—Crohn's disease	0.00174	0.00291	CcSEcCtD
Paliperidone—Erythema—Mesalazine—Crohn's disease	0.00173	0.00289	CcSEcCtD
Paliperidone—Malaise—Azathioprine—Crohn's disease	0.00172	0.00286	CcSEcCtD
Paliperidone—Flatulence—Mesalazine—Crohn's disease	0.00171	0.00284	CcSEcCtD
Paliperidone—Leukopenia—Azathioprine—Crohn's disease	0.0017	0.00284	CcSEcCtD
Paliperidone—Tension—Mesalazine—Crohn's disease	0.0017	0.00283	CcSEcCtD
Paliperidone—Dysgeusia—Mesalazine—Crohn's disease	0.0017	0.00283	CcSEcCtD
Paliperidone—Nervousness—Mesalazine—Crohn's disease	0.00168	0.0028	CcSEcCtD
Paliperidone—Back pain—Mesalazine—Crohn's disease	0.00168	0.00279	CcSEcCtD
Paliperidone—Muscle spasms—Mesalazine—Crohn's disease	0.00167	0.00278	CcSEcCtD
Paliperidone—Vomiting—Mercaptopurine—Crohn's disease	0.00166	0.00276	CcSEcCtD
Paliperidone—Rash—Mercaptopurine—Crohn's disease	0.00164	0.00274	CcSEcCtD
Paliperidone—Dermatitis—Mercaptopurine—Crohn's disease	0.00164	0.00273	CcSEcCtD
Paliperidone—Vision blurred—Mesalazine—Crohn's disease	0.00163	0.00272	CcSEcCtD
Paliperidone—Tremor—Mesalazine—Crohn's disease	0.00162	0.0027	CcSEcCtD
Paliperidone—Increased appetite—Prednisone—Crohn's disease	0.00162	0.0027	CcSEcCtD
Paliperidone—Myalgia—Azathioprine—Crohn's disease	0.00162	0.0027	CcSEcCtD
Paliperidone—Arthralgia—Azathioprine—Crohn's disease	0.00162	0.0027	CcSEcCtD
Paliperidone—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—Crohn's disease	0.00161	0.00268	CcSEcCtD
Paliperidone—Ill-defined disorder—Mesalazine—Crohn's disease	0.00161	0.00268	CcSEcCtD
Paliperidone—Anaemia—Mesalazine—Crohn's disease	0.0016	0.00267	CcSEcCtD
Paliperidone—Discomfort—Azathioprine—Crohn's disease	0.0016	0.00267	CcSEcCtD
Paliperidone—Angioedema—Mesalazine—Crohn's disease	0.00158	0.00264	CcSEcCtD
Paliperidone—Malaise—Mesalazine—Crohn's disease	0.00156	0.0026	CcSEcCtD
Paliperidone—Vertigo—Mesalazine—Crohn's disease	0.00156	0.00259	CcSEcCtD
Paliperidone—Syncope—Mesalazine—Crohn's disease	0.00155	0.00259	CcSEcCtD
Paliperidone—Lethargy—Prednisone—Crohn's disease	0.00155	0.00259	CcSEcCtD
Paliperidone—Leukopenia—Mesalazine—Crohn's disease	0.00155	0.00258	CcSEcCtD
Paliperidone—Nausea—Mercaptopurine—Crohn's disease	0.00155	0.00258	CcSEcCtD
Paliperidone—Infection—Azathioprine—Crohn's disease	0.00154	0.00257	CcSEcCtD
Paliperidone—Palpitations—Mesalazine—Crohn's disease	0.00153	0.00255	CcSEcCtD
Paliperidone—Loss of consciousness—Mesalazine—Crohn's disease	0.00152	0.00254	CcSEcCtD
Paliperidone—Osteoarthritis—Prednisone—Crohn's disease	0.00152	0.00254	CcSEcCtD
Paliperidone—Thrombocytopenia—Azathioprine—Crohn's disease	0.00152	0.00253	CcSEcCtD
Paliperidone—Cough—Mesalazine—Crohn's disease	0.00151	0.00252	CcSEcCtD
Paliperidone—Skin disorder—Azathioprine—Crohn's disease	0.00151	0.00251	CcSEcCtD
Paliperidone—Hypertension—Mesalazine—Crohn's disease	0.0015	0.00249	CcSEcCtD
Paliperidone—Myalgia—Mesalazine—Crohn's disease	0.00148	0.00246	CcSEcCtD
Paliperidone—Arthralgia—Mesalazine—Crohn's disease	0.00148	0.00246	CcSEcCtD
Paliperidone—Chest pain—Mesalazine—Crohn's disease	0.00148	0.00246	CcSEcCtD
Paliperidone—Anxiety—Mesalazine—Crohn's disease	0.00147	0.00245	CcSEcCtD
Paliperidone—Face oedema—Prednisone—Crohn's disease	0.00147	0.00245	CcSEcCtD
Paliperidone—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—Crohn's disease	0.00147	0.00244	CcSEcCtD
Paliperidone—Discomfort—Mesalazine—Crohn's disease	0.00146	0.00243	CcSEcCtD
Paliperidone—Hypotension—Azathioprine—Crohn's disease	0.00145	0.00242	CcSEcCtD
Paliperidone—Cardiac arrest—Prednisone—Crohn's disease	0.00145	0.00241	CcSEcCtD
Paliperidone—Dry mouth—Mesalazine—Crohn's disease	0.00144	0.0024	CcSEcCtD
Paliperidone—Confusional state—Mesalazine—Crohn's disease	0.00143	0.00238	CcSEcCtD
Paliperidone—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.00142	0.00236	CcSEcCtD
Paliperidone—Oedema—Mesalazine—Crohn's disease	0.00141	0.00236	CcSEcCtD
Paliperidone—Anaphylactic shock—Mesalazine—Crohn's disease	0.00141	0.00236	CcSEcCtD
Paliperidone—Infection—Mesalazine—Crohn's disease	0.00141	0.00234	CcSEcCtD
Paliperidone—Dry skin—Prednisone—Crohn's disease	0.0014	0.00233	CcSEcCtD
Paliperidone—Shock—Mesalazine—Crohn's disease	0.00139	0.00232	CcSEcCtD
Paliperidone—Nervous system disorder—Mesalazine—Crohn's disease	0.00139	0.00231	CcSEcCtD
Paliperidone—Thrombocytopenia—Mesalazine—Crohn's disease	0.00139	0.00231	CcSEcCtD
Paliperidone—Tachycardia—Mesalazine—Crohn's disease	0.00138	0.0023	CcSEcCtD
Paliperidone—Skin disorder—Mesalazine—Crohn's disease	0.00137	0.00229	CcSEcCtD
Paliperidone—Anorexia—Mesalazine—Crohn's disease	0.00135	0.00225	CcSEcCtD
Paliperidone—Alanine aminotransferase increased—Prednisone—Crohn's disease	0.00134	0.00224	CcSEcCtD
Paliperidone—Muscular weakness—Prednisone—Crohn's disease	0.00134	0.00224	CcSEcCtD
Paliperidone—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.00134	0.00223	CcSEcCtD
Paliperidone—Hypotension—Mesalazine—Crohn's disease	0.00132	0.0022	CcSEcCtD
Paliperidone—Pancreatitis—Prednisone—Crohn's disease	0.00129	0.00215	CcSEcCtD
Paliperidone—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.00129	0.00215	CcSEcCtD
Paliperidone—Feeling abnormal—Azathioprine—Crohn's disease	0.00128	0.00213	CcSEcCtD
Paliperidone—Insomnia—Mesalazine—Crohn's disease	0.00128	0.00213	CcSEcCtD
Paliperidone—Paraesthesia—Mesalazine—Crohn's disease	0.00127	0.00212	CcSEcCtD
Paliperidone—Gastrointestinal pain—Azathioprine—Crohn's disease	0.00127	0.00212	CcSEcCtD
Paliperidone—Dyspnoea—Mesalazine—Crohn's disease	0.00126	0.0021	CcSEcCtD
Paliperidone—Somnolence—Mesalazine—Crohn's disease	0.00126	0.00209	CcSEcCtD
Paliperidone—Dyspepsia—Mesalazine—Crohn's disease	0.00125	0.00207	CcSEcCtD
Paliperidone—Neutropenia—Prednisone—Crohn's disease	0.00123	0.00205	CcSEcCtD
Paliperidone—Decreased appetite—Mesalazine—Crohn's disease	0.00123	0.00205	CcSEcCtD
Paliperidone—Abdominal pain—Azathioprine—Crohn's disease	0.00123	0.00204	CcSEcCtD
Paliperidone—Body temperature increased—Azathioprine—Crohn's disease	0.00123	0.00204	CcSEcCtD
Paliperidone—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.00122	0.00203	CcSEcCtD
Paliperidone—Fatigue—Mesalazine—Crohn's disease	0.00122	0.00203	CcSEcCtD
Paliperidone—Erectile dysfunction—Prednisone—Crohn's disease	0.00121	0.00202	CcSEcCtD
Paliperidone—Pain—Mesalazine—Crohn's disease	0.00121	0.00202	CcSEcCtD
Paliperidone—Constipation—Mesalazine—Crohn's disease	0.00121	0.00202	CcSEcCtD
Paliperidone—Weight increased—Prednisone—Crohn's disease	0.0012	0.002	CcSEcCtD
Paliperidone—Weight decreased—Prednisone—Crohn's disease	0.00119	0.00198	CcSEcCtD
Paliperidone—Hyperglycaemia—Prednisone—Crohn's disease	0.00119	0.00198	CcSEcCtD
Paliperidone—Depression—Prednisone—Crohn's disease	0.00117	0.00195	CcSEcCtD
Paliperidone—Feeling abnormal—Mesalazine—Crohn's disease	0.00117	0.00194	CcSEcCtD
Paliperidone—Gastrointestinal pain—Mesalazine—Crohn's disease	0.00116	0.00193	CcSEcCtD
Paliperidone—Hypersensitivity—Azathioprine—Crohn's disease	0.00114	0.00191	CcSEcCtD
Paliperidone—Urticaria—Mesalazine—Crohn's disease	0.00112	0.00187	CcSEcCtD
Paliperidone—Abdominal pain—Mesalazine—Crohn's disease	0.00112	0.00186	CcSEcCtD
Paliperidone—Body temperature increased—Mesalazine—Crohn's disease	0.00112	0.00186	CcSEcCtD
Paliperidone—Bradycardia—Prednisone—Crohn's disease	0.00107	0.00179	CcSEcCtD
Paliperidone—Diarrhoea—Azathioprine—Crohn's disease	0.00106	0.00177	CcSEcCtD
Paliperidone—Hypersensitivity—Mesalazine—Crohn's disease	0.00104	0.00174	CcSEcCtD
Paliperidone—Connective tissue disorder—Prednisone—Crohn's disease	0.00104	0.00172	CcSEcCtD
Paliperidone—Dizziness—Azathioprine—Crohn's disease	0.00103	0.00171	CcSEcCtD
Paliperidone—Asthenia—Mesalazine—Crohn's disease	0.00102	0.00169	CcSEcCtD
Paliperidone—Pruritus—Mesalazine—Crohn's disease	0.001	0.00167	CcSEcCtD
Paliperidone—Vomiting—Azathioprine—Crohn's disease	0.000988	0.00164	CcSEcCtD
Paliperidone—Eye disorder—Prednisone—Crohn's disease	0.000985	0.00164	CcSEcCtD
Paliperidone—Rash—Azathioprine—Crohn's disease	0.000979	0.00163	CcSEcCtD
Paliperidone—Dermatitis—Azathioprine—Crohn's disease	0.000978	0.00163	CcSEcCtD
Paliperidone—Flushing—Prednisone—Crohn's disease	0.000978	0.00163	CcSEcCtD
Paliperidone—Headache—Azathioprine—Crohn's disease	0.000973	0.00162	CcSEcCtD
Paliperidone—Diarrhoea—Mesalazine—Crohn's disease	0.000968	0.00161	CcSEcCtD
Paliperidone—Angiopathy—Prednisone—Crohn's disease	0.000956	0.00159	CcSEcCtD
Paliperidone—Immune system disorder—Prednisone—Crohn's disease	0.000952	0.00158	CcSEcCtD
Paliperidone—Dizziness—Mesalazine—Crohn's disease	0.000936	0.00156	CcSEcCtD
Paliperidone—Alopecia—Prednisone—Crohn's disease	0.000931	0.00155	CcSEcCtD
Paliperidone—Mental disorder—Prednisone—Crohn's disease	0.000923	0.00154	CcSEcCtD
Paliperidone—Nausea—Azathioprine—Crohn's disease	0.000923	0.00154	CcSEcCtD
Paliperidone—Malnutrition—Prednisone—Crohn's disease	0.000917	0.00153	CcSEcCtD
Paliperidone—Erythema—Prednisone—Crohn's disease	0.000917	0.00153	CcSEcCtD
Paliperidone—Vomiting—Mesalazine—Crohn's disease	0.0009	0.0015	CcSEcCtD
Paliperidone—Rash—Mesalazine—Crohn's disease	0.000892	0.00149	CcSEcCtD
Paliperidone—Dermatitis—Mesalazine—Crohn's disease	0.000891	0.00148	CcSEcCtD
Paliperidone—Headache—Mesalazine—Crohn's disease	0.000886	0.00148	CcSEcCtD
Paliperidone—Vision blurred—Prednisone—Crohn's disease	0.000864	0.00144	CcSEcCtD
Paliperidone—Ill-defined disorder—Prednisone—Crohn's disease	0.000851	0.00142	CcSEcCtD
Paliperidone—Anaemia—Prednisone—Crohn's disease	0.000848	0.00141	CcSEcCtD
Paliperidone—Agitation—Prednisone—Crohn's disease	0.000843	0.0014	CcSEcCtD
Paliperidone—Nausea—Mesalazine—Crohn's disease	0.00084	0.0014	CcSEcCtD
Paliperidone—Angioedema—Prednisone—Crohn's disease	0.000838	0.0014	CcSEcCtD
Paliperidone—Malaise—Prednisone—Crohn's disease	0.000827	0.00138	CcSEcCtD
Paliperidone—Vertigo—Prednisone—Crohn's disease	0.000824	0.00137	CcSEcCtD
Paliperidone—Syncope—Prednisone—Crohn's disease	0.000823	0.00137	CcSEcCtD
Paliperidone—Loss of consciousness—Prednisone—Crohn's disease	0.000806	0.00134	CcSEcCtD
Paliperidone—Convulsion—Prednisone—Crohn's disease	0.000795	0.00132	CcSEcCtD
Paliperidone—Hypertension—Prednisone—Crohn's disease	0.000792	0.00132	CcSEcCtD
Paliperidone—Myalgia—Prednisone—Crohn's disease	0.000781	0.0013	CcSEcCtD
Paliperidone—Arthralgia—Prednisone—Crohn's disease	0.000781	0.0013	CcSEcCtD
Paliperidone—Anxiety—Prednisone—Crohn's disease	0.000778	0.0013	CcSEcCtD
Paliperidone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—Crohn's disease	0.000776	0.00129	CcSEcCtD
Paliperidone—Discomfort—Prednisone—Crohn's disease	0.000772	0.00128	CcSEcCtD
Paliperidone—Anaphylactic shock—Prednisone—Crohn's disease	0.000749	0.00125	CcSEcCtD
Paliperidone—Oedema—Prednisone—Crohn's disease	0.000749	0.00125	CcSEcCtD
Paliperidone—Infection—Prednisone—Crohn's disease	0.000744	0.00124	CcSEcCtD
Paliperidone—Shock—Prednisone—Crohn's disease	0.000737	0.00123	CcSEcCtD
Paliperidone—Nervous system disorder—Prednisone—Crohn's disease	0.000734	0.00122	CcSEcCtD
Paliperidone—Tachycardia—Prednisone—Crohn's disease	0.000731	0.00122	CcSEcCtD
Paliperidone—Skin disorder—Prednisone—Crohn's disease	0.000727	0.00121	CcSEcCtD
Paliperidone—Anorexia—Prednisone—Crohn's disease	0.000714	0.00119	CcSEcCtD
Paliperidone—Musculoskeletal discomfort—Prednisone—Crohn's disease	0.000682	0.00114	CcSEcCtD
Paliperidone—Insomnia—Prednisone—Crohn's disease	0.000677	0.00113	CcSEcCtD
Paliperidone—Paraesthesia—Prednisone—Crohn's disease	0.000672	0.00112	CcSEcCtD
Paliperidone—Dyspepsia—Prednisone—Crohn's disease	0.000659	0.0011	CcSEcCtD
Paliperidone—Decreased appetite—Prednisone—Crohn's disease	0.000651	0.00108	CcSEcCtD
Paliperidone—Fatigue—Prednisone—Crohn's disease	0.000645	0.00107	CcSEcCtD
Paliperidone—Constipation—Prednisone—Crohn's disease	0.00064	0.00107	CcSEcCtD
Paliperidone—Feeling abnormal—Prednisone—Crohn's disease	0.000617	0.00103	CcSEcCtD
Paliperidone—Gastrointestinal pain—Prednisone—Crohn's disease	0.000612	0.00102	CcSEcCtD
Paliperidone—Urticaria—Prednisone—Crohn's disease	0.000595	0.00099	CcSEcCtD
Paliperidone—Body temperature increased—Prednisone—Crohn's disease	0.000592	0.000986	CcSEcCtD
Paliperidone—Abdominal pain—Prednisone—Crohn's disease	0.000592	0.000986	CcSEcCtD
Paliperidone—Hypersensitivity—Prednisone—Crohn's disease	0.000552	0.000919	CcSEcCtD
Paliperidone—Asthenia—Prednisone—Crohn's disease	0.000537	0.000894	CcSEcCtD
Paliperidone—Pruritus—Prednisone—Crohn's disease	0.00053	0.000882	CcSEcCtD
Paliperidone—Diarrhoea—Prednisone—Crohn's disease	0.000512	0.000853	CcSEcCtD
Paliperidone—Dizziness—Prednisone—Crohn's disease	0.000495	0.000824	CcSEcCtD
Paliperidone—Vomiting—Prednisone—Crohn's disease	0.000476	0.000793	CcSEcCtD
Paliperidone—Rash—Prednisone—Crohn's disease	0.000472	0.000786	CcSEcCtD
Paliperidone—Dermatitis—Prednisone—Crohn's disease	0.000472	0.000785	CcSEcCtD
Paliperidone—Headache—Prednisone—Crohn's disease	0.000469	0.000781	CcSEcCtD
Paliperidone—Nausea—Prednisone—Crohn's disease	0.000445	0.000741	CcSEcCtD
Paliperidone—HTR2C—Signaling Pathways—RIPK2—Crohn's disease	8.7e-05	0.000218	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—SOCS1—Crohn's disease	8.69e-05	0.000217	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—SMAD3—Crohn's disease	8.65e-05	0.000216	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—PTGER4—Crohn's disease	8.65e-05	0.000216	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—PTGER4—Crohn's disease	8.63e-05	0.000216	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—GPX4—Crohn's disease	8.6e-05	0.000215	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—UBE2D1—Crohn's disease	8.58e-05	0.000215	CbGpPWpGaD
Paliperidone—DRD3—GPCR downstream signaling—JAK2—Crohn's disease	8.58e-05	0.000215	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—SOCS1—Crohn's disease	8.57e-05	0.000214	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling by GPCR—IL2RA—Crohn's disease	8.55e-05	0.000214	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—RASGRP1—Crohn's disease	8.54e-05	0.000214	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—IL3—Crohn's disease	8.52e-05	0.000213	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—IL3—Crohn's disease	8.48e-05	0.000212	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—SMAD3—Crohn's disease	8.47e-05	0.000212	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—PTGER4—Crohn's disease	8.47e-05	0.000212	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—RIPK2—Crohn's disease	8.46e-05	0.000212	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—SMAD3—Crohn's disease	8.33e-05	0.000208	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—RIPK2—Crohn's disease	8.32e-05	0.000208	CbGpPWpGaD
Paliperidone—HTR1D—Signaling by GPCR—CXCL8—Crohn's disease	8.31e-05	0.000208	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—GCKR—Crohn's disease	8.31e-05	0.000208	CbGpPWpGaD
Paliperidone—DRD1—Signaling by GPCR—TYK2—Crohn's disease	8.28e-05	0.000207	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—IL3—Crohn's disease	8.25e-05	0.000206	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—RASGRP1—Crohn's disease	8.24e-05	0.000206	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—RASGRP1—Crohn's disease	8.2e-05	0.000205	CbGpPWpGaD
Paliperidone—DRD3—Signaling by GPCR—TYK2—Crohn's disease	8.17e-05	0.000205	CbGpPWpGaD
Paliperidone—HTR1B—Signaling by GPCR—CXCL8—Crohn's disease	8.14e-05	0.000204	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—IL3—Crohn's disease	8.12e-05	0.000203	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—RBX1—Crohn's disease	8.08e-05	0.000202	CbGpPWpGaD
Paliperidone—DRD4—Signaling by GPCR—CXCL8—Crohn's disease	8.01e-05	0.0002	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—IL2RA—Crohn's disease	8e-05	0.0002	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—RASGRP1—Crohn's disease	7.98e-05	0.0002	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling by GPCR—IL2RA—Crohn's disease	7.94e-05	0.000199	CbGpPWpGaD
Paliperidone—DRD1—GPCR downstream signaling—CXCL8—Crohn's disease	7.94e-05	0.000199	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—UBE2D1—Crohn's disease	7.91e-05	0.000198	CbGpPWpGaD
Paliperidone—DRD1—Signaling by GPCR—JAK2—Crohn's disease	7.9e-05	0.000198	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—PTGER4—Crohn's disease	7.87e-05	0.000197	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—RASGRP1—Crohn's disease	7.85e-05	0.000197	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—IL2RA—Crohn's disease	7.84e-05	0.000196	CbGpPWpGaD
Paliperidone—DRD3—GPCR downstream signaling—CXCL8—Crohn's disease	7.83e-05	0.000196	CbGpPWpGaD
Paliperidone—DRD3—Signaling by GPCR—JAK2—Crohn's disease	7.8e-05	0.000195	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—UBE2D1—Crohn's disease	7.79e-05	0.000195	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—UBE2D1—Crohn's disease	7.77e-05	0.000194	CbGpPWpGaD
Paliperidone—ADRA2B—GPCR downstream signaling—JAK2—Crohn's disease	7.75e-05	0.000194	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—SOCS1—Crohn's disease	7.74e-05	0.000194	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—IL2RA—Crohn's disease	7.71e-05	0.000193	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—MTMR3—Crohn's disease	7.71e-05	0.000193	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—RIPK2—Crohn's disease	7.67e-05	0.000192	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—UBE2D1—Crohn's disease	7.62e-05	0.000191	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—RIPK2—Crohn's disease	7.55e-05	0.000189	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—RIPK2—Crohn's disease	7.53e-05	0.000189	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—SMAD3—Crohn's disease	7.5e-05	0.000188	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—IL3—Crohn's disease	7.48e-05	0.000187	CbGpPWpGaD
Paliperidone—HTR1A—GPCR downstream signaling—JAK2—Crohn's disease	7.48e-05	0.000187	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—SOCS1—Crohn's disease	7.47e-05	0.000187	CbGpPWpGaD
Paliperidone—HTR2C—GPCR downstream signaling—JAK2—Crohn's disease	7.44e-05	0.000186	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—SOCS1—Crohn's disease	7.43e-05	0.000186	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—SMAD3—Crohn's disease	7.4e-05	0.000185	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—RIPK2—Crohn's disease	7.39e-05	0.000185	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling by GPCR—TYK2—Crohn's disease	7.38e-05	0.000185	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—IL3—Crohn's disease	7.36e-05	0.000184	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—IL3—Crohn's disease	7.35e-05	0.000184	CbGpPWpGaD
Paliperidone—ADRA2C—GPCR downstream signaling—JAK2—Crohn's disease	7.24e-05	0.000181	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—RASGRP1—Crohn's disease	7.24e-05	0.000181	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—SOCS1—Crohn's disease	7.23e-05	0.000181	CbGpPWpGaD
Paliperidone—DRD1—Signaling by GPCR—CXCL8—Crohn's disease	7.21e-05	0.00018	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—IL3—Crohn's disease	7.21e-05	0.00018	CbGpPWpGaD
Paliperidone—ADRA1B—GPCR downstream signaling—JAK2—Crohn's disease	7.12e-05	0.000178	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—RASGRP1—Crohn's disease	7.12e-05	0.000178	CbGpPWpGaD
Paliperidone—HTR1A—Signaling by GPCR—TYK2—Crohn's disease	7.12e-05	0.000178	CbGpPWpGaD
Paliperidone—DRD3—Signaling by GPCR—CXCL8—Crohn's disease	7.11e-05	0.000178	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—SOCS1—Crohn's disease	7.11e-05	0.000178	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—RASGRP1—Crohn's disease	7.11e-05	0.000178	CbGpPWpGaD
Paliperidone—HTR2C—Signaling by GPCR—TYK2—Crohn's disease	7.08e-05	0.000177	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—UBE2D1—Crohn's disease	7.08e-05	0.000177	CbGpPWpGaD
Paliperidone—ADRA2B—GPCR downstream signaling—CXCL8—Crohn's disease	7.07e-05	0.000177	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling by GPCR—JAK2—Crohn's disease	7.04e-05	0.000176	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—RASGRP1—Crohn's disease	6.97e-05	0.000175	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—IL2RA—Crohn's disease	6.94e-05	0.000174	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling by GPCR—TYK2—Crohn's disease	6.89e-05	0.000172	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—RIPK2—Crohn's disease	6.87e-05	0.000172	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—IL2RA—Crohn's disease	6.85e-05	0.000171	CbGpPWpGaD
Paliperidone—HTR1A—GPCR downstream signaling—CXCL8—Crohn's disease	6.83e-05	0.000171	CbGpPWpGaD
Paliperidone—HTR1A—Signaling by GPCR—JAK2—Crohn's disease	6.79e-05	0.00017	CbGpPWpGaD
Paliperidone—HTR2C—GPCR downstream signaling—CXCL8—Crohn's disease	6.79e-05	0.00017	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling by GPCR—TYK2—Crohn's disease	6.78e-05	0.00017	CbGpPWpGaD
Paliperidone—HTR2C—Signaling by GPCR—JAK2—Crohn's disease	6.76e-05	0.000169	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—IL3—Crohn's disease	6.7e-05	0.000168	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—SMAD3—Crohn's disease	6.68e-05	0.000167	CbGpPWpGaD
Paliperidone—ADRA2C—GPCR downstream signaling—CXCL8—Crohn's disease	6.61e-05	0.000165	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling by GPCR—JAK2—Crohn's disease	6.57e-05	0.000165	CbGpPWpGaD
Paliperidone—DRD2—GPCR downstream signaling—JAK2—Crohn's disease	6.57e-05	0.000164	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—SOCS1—Crohn's disease	6.56e-05	0.000164	CbGpPWpGaD
Paliperidone—ADRA1B—GPCR downstream signaling—CXCL8—Crohn's disease	6.5e-05	0.000163	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—RASGRP1—Crohn's disease	6.48e-05	0.000162	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling by GPCR—JAK2—Crohn's disease	6.47e-05	0.000162	CbGpPWpGaD
Paliperidone—HTR2A—GPCR downstream signaling—JAK2—Crohn's disease	6.46e-05	0.000162	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—SOCS1—Crohn's disease	6.45e-05	0.000161	CbGpPWpGaD
Paliperidone—HRH1—GPCR downstream signaling—JAK2—Crohn's disease	6.45e-05	0.000161	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—SMAD3—Crohn's disease	6.45e-05	0.000161	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—SOCS1—Crohn's disease	6.44e-05	0.000161	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling by GPCR—CXCL8—Crohn's disease	6.42e-05	0.000161	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—SMAD3—Crohn's disease	6.42e-05	0.000161	CbGpPWpGaD
Paliperidone—ADRA1A—GPCR downstream signaling—JAK2—Crohn's disease	6.33e-05	0.000158	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—SOCS1—Crohn's disease	6.32e-05	0.000158	CbGpPWpGaD
Paliperidone—DRD2—Signaling by GPCR—TYK2—Crohn's disease	6.25e-05	0.000156	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—SMAD3—Crohn's disease	6.24e-05	0.000156	CbGpPWpGaD
Paliperidone—HTR1A—Signaling by GPCR—CXCL8—Crohn's disease	6.2e-05	0.000155	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—IL2RA—Crohn's disease	6.19e-05	0.000155	CbGpPWpGaD
Paliperidone—HTR2C—Signaling by GPCR—CXCL8—Crohn's disease	6.17e-05	0.000154	CbGpPWpGaD
Paliperidone—HTR2A—Signaling by GPCR—TYK2—Crohn's disease	6.15e-05	0.000154	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—SMAD3—Crohn's disease	6.14e-05	0.000154	CbGpPWpGaD
Paliperidone—HRH1—Signaling by GPCR—TYK2—Crohn's disease	6.14e-05	0.000154	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling by GPCR—TYK2—Crohn's disease	6.02e-05	0.000151	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—FADS1—Crohn's disease	6.01e-05	0.00015	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling by GPCR—CXCL8—Crohn's disease	6e-05	0.00015	CbGpPWpGaD
Paliperidone—DRD2—GPCR downstream signaling—CXCL8—Crohn's disease	5.99e-05	0.00015	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—IL2RA—Crohn's disease	5.97e-05	0.000149	CbGpPWpGaD
Paliperidone—DRD2—Signaling by GPCR—JAK2—Crohn's disease	5.96e-05	0.000149	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—IL2RA—Crohn's disease	5.94e-05	0.000149	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling by GPCR—CXCL8—Crohn's disease	5.9e-05	0.000148	CbGpPWpGaD
Paliperidone—HTR2A—GPCR downstream signaling—CXCL8—Crohn's disease	5.9e-05	0.000148	CbGpPWpGaD
Paliperidone—HRH1—GPCR downstream signaling—CXCL8—Crohn's disease	5.89e-05	0.000147	CbGpPWpGaD
Paliperidone—ADRA2A—GPCR downstream signaling—JAK2—Crohn's disease	5.88e-05	0.000147	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—SOCS1—Crohn's disease	5.87e-05	0.000147	CbGpPWpGaD
Paliperidone—HTR2A—Signaling by GPCR—JAK2—Crohn's disease	5.87e-05	0.000147	CbGpPWpGaD
Paliperidone—HRH1—Signaling by GPCR—JAK2—Crohn's disease	5.86e-05	0.000147	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—IL2RA—Crohn's disease	5.78e-05	0.000145	CbGpPWpGaD
Paliperidone—ADRA1A—GPCR downstream signaling—CXCL8—Crohn's disease	5.78e-05	0.000145	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling by GPCR—JAK2—Crohn's disease	5.75e-05	0.000144	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—IL2RA—Crohn's disease	5.69e-05	0.000142	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—SMAD3—Crohn's disease	5.66e-05	0.000142	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—TYK2—Crohn's disease	5.64e-05	0.000141	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—GPX4—Crohn's disease	5.62e-05	0.000141	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling by GPCR—TYK2—Crohn's disease	5.6e-05	0.00014	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—SMAD3—Crohn's disease	5.57e-05	0.000139	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—SMAD3—Crohn's disease	5.56e-05	0.000139	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—TYK2—Crohn's disease	5.52e-05	0.000138	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—SMAD3—Crohn's disease	5.45e-05	0.000137	CbGpPWpGaD
Paliperidone—DRD2—Signaling by GPCR—CXCL8—Crohn's disease	5.44e-05	0.000136	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—TYK2—Crohn's disease	5.43e-05	0.000136	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—GCKR—Crohn's disease	5.43e-05	0.000136	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—JAK2—Crohn's disease	5.38e-05	0.000135	CbGpPWpGaD
Paliperidone—ADRA2A—GPCR downstream signaling—CXCL8—Crohn's disease	5.37e-05	0.000134	CbGpPWpGaD
Paliperidone—HTR2A—Signaling by GPCR—CXCL8—Crohn's disease	5.36e-05	0.000134	CbGpPWpGaD
Paliperidone—HRH1—Signaling by GPCR—CXCL8—Crohn's disease	5.35e-05	0.000134	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling by GPCR—JAK2—Crohn's disease	5.34e-05	0.000134	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—JAK2—Crohn's disease	5.27e-05	0.000132	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling by GPCR—CXCL8—Crohn's disease	5.25e-05	0.000131	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—IL2RA—Crohn's disease	5.24e-05	0.000131	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—JAK2—Crohn's disease	5.18e-05	0.00013	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—IL2RA—Crohn's disease	5.16e-05	0.000129	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—IL2RA—Crohn's disease	5.15e-05	0.000129	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—SMAD3—Crohn's disease	5.07e-05	0.000127	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—IL2RA—Crohn's disease	5.05e-05	0.000126	CbGpPWpGaD
Paliperidone—ADRA2C—Metabolism—ALB—Crohn's disease	5e-05	0.000125	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—CXCL8—Crohn's disease	4.91e-05	0.000123	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—TYK2—Crohn's disease	4.89e-05	0.000122	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling by GPCR—CXCL8—Crohn's disease	4.87e-05	0.000122	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—TYK2—Crohn's disease	4.83e-05	0.000121	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—CXCL8—Crohn's disease	4.81e-05	0.00012	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—CXCL8—Crohn's disease	4.73e-05	0.000118	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—IL2RA—Crohn's disease	4.69e-05	0.000117	CbGpPWpGaD
Paliperidone—HTR1D—Signaling by GPCR—IL6—Crohn's disease	4.67e-05	0.000117	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—JAK2—Crohn's disease	4.67e-05	0.000117	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—JAK2—Crohn's disease	4.6e-05	0.000115	CbGpPWpGaD
Paliperidone—HTR1B—Signaling by GPCR—IL6—Crohn's disease	4.57e-05	0.000114	CbGpPWpGaD
Paliperidone—DRD4—Signaling by GPCR—IL6—Crohn's disease	4.5e-05	0.000113	CbGpPWpGaD
Paliperidone—ADRA2C—Metabolism—PTGS2—Crohn's disease	4.37e-05	0.000109	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—TYK2—Crohn's disease	4.36e-05	0.000109	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—CXCL8—Crohn's disease	4.26e-05	0.000107	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—TYK2—Crohn's disease	4.21e-05	0.000105	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—CXCL8—Crohn's disease	4.2e-05	0.000105	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—TYK2—Crohn's disease	4.19e-05	0.000105	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—JAK2—Crohn's disease	4.16e-05	0.000104	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—TYK2—Crohn's disease	4.07e-05	0.000102	CbGpPWpGaD
Paliperidone—ADRA2A—Metabolism—ALB—Crohn's disease	4.06e-05	0.000102	CbGpPWpGaD
Paliperidone—DRD1—Signaling by GPCR—IL6—Crohn's disease	4.05e-05	0.000101	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—JAK2—Crohn's disease	4.01e-05	0.0001	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—TYK2—Crohn's disease	4.01e-05	0.0001	CbGpPWpGaD
Paliperidone—DRD3—Signaling by GPCR—IL6—Crohn's disease	4e-05	0.0001	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—JAK2—Crohn's disease	3.99e-05	9.99e-05	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—STAT3—Crohn's disease	3.95e-05	9.88e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—JAK2—Crohn's disease	3.88e-05	9.72e-05	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—STAT3—Crohn's disease	3.87e-05	9.68e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—JAK2—Crohn's disease	3.82e-05	9.57e-05	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—STAT3—Crohn's disease	3.81e-05	9.52e-05	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—CXCL8—Crohn's disease	3.79e-05	9.5e-05	CbGpPWpGaD
Paliperidone—CYP3A5—Metabolism—ALB—Crohn's disease	3.72e-05	9.31e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—TYK2—Crohn's disease	3.69e-05	9.24e-05	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—CXCL8—Crohn's disease	3.66e-05	9.17e-05	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—CXCL8—Crohn's disease	3.64e-05	9.12e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—TYK2—Crohn's disease	3.63e-05	9.1e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—TYK2—Crohn's disease	3.63e-05	9.08e-05	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling by GPCR—IL6—Crohn's disease	3.61e-05	9.03e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—TYK2—Crohn's disease	3.56e-05	8.91e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Metabolism—PTGS2—Crohn's disease	3.55e-05	8.89e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—CXCL8—Crohn's disease	3.54e-05	8.87e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—JAK2—Crohn's disease	3.52e-05	8.82e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—CXCL8—Crohn's disease	3.49e-05	8.73e-05	CbGpPWpGaD
Paliperidone—HTR1A—Signaling by GPCR—IL6—Crohn's disease	3.48e-05	8.72e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—JAK2—Crohn's disease	3.47e-05	8.68e-05	CbGpPWpGaD
Paliperidone—HTR2C—Signaling by GPCR—IL6—Crohn's disease	3.47e-05	8.67e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—JAK2—Crohn's disease	3.46e-05	8.66e-05	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—STAT3—Crohn's disease	3.43e-05	8.57e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—JAK2—Crohn's disease	3.39e-05	8.5e-05	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—STAT3—Crohn's disease	3.38e-05	8.46e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling by GPCR—IL6—Crohn's disease	3.37e-05	8.44e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling by GPCR—IL6—Crohn's disease	3.32e-05	8.3e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—TYK2—Crohn's disease	3.31e-05	8.28e-05	CbGpPWpGaD
Paliperidone—CYP3A5—Metabolism—PTGS2—Crohn's disease	3.25e-05	8.14e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—CXCL8—Crohn's disease	3.22e-05	8.05e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—CXCL8—Crohn's disease	3.16e-05	7.92e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—CXCL8—Crohn's disease	3.16e-05	7.9e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—JAK2—Crohn's disease	3.15e-05	7.89e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—CXCL8—Crohn's disease	3.1e-05	7.76e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling by GPCR—IL6—Crohn's disease	3.06e-05	7.65e-05	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—STAT3—Crohn's disease	3.05e-05	7.64e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling by GPCR—IL6—Crohn's disease	3.01e-05	7.53e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling by GPCR—IL6—Crohn's disease	3e-05	7.51e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling by GPCR—IL6—Crohn's disease	2.95e-05	7.37e-05	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—STAT3—Crohn's disease	2.95e-05	7.37e-05	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—STAT3—Crohn's disease	2.93e-05	7.33e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—CXCL8—Crohn's disease	2.88e-05	7.21e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—STAT3—Crohn's disease	2.85e-05	7.13e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—STAT3—Crohn's disease	2.81e-05	7.02e-05	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—IL6—Crohn's disease	2.76e-05	6.9e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling by GPCR—IL6—Crohn's disease	2.74e-05	6.85e-05	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—IL6—Crohn's disease	2.7e-05	6.76e-05	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—IL6—Crohn's disease	2.66e-05	6.65e-05	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—ALB—Crohn's disease	2.64e-05	6.62e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—STAT3—Crohn's disease	2.59e-05	6.47e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—STAT3—Crohn's disease	2.54e-05	6.37e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—STAT3—Crohn's disease	2.54e-05	6.36e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—STAT3—Crohn's disease	2.49e-05	6.24e-05	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—IL6—Crohn's disease	2.39e-05	5.99e-05	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—IL6—Crohn's disease	2.36e-05	5.91e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—STAT3—Crohn's disease	2.32e-05	5.79e-05	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—PTGS2—Crohn's disease	2.31e-05	5.79e-05	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—IL6—Crohn's disease	2.13e-05	5.33e-05	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—IL6—Crohn's disease	2.06e-05	5.15e-05	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—IL6—Crohn's disease	2.05e-05	5.12e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—IL6—Crohn's disease	1.99e-05	4.98e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—IL6—Crohn's disease	1.96e-05	4.9e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—IL6—Crohn's disease	1.81e-05	4.52e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—IL6—Crohn's disease	1.78e-05	4.45e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—IL6—Crohn's disease	1.77e-05	4.44e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—IL6—Crohn's disease	1.74e-05	4.36e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—ALB—Crohn's disease	1.73e-05	4.33e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—IL6—Crohn's disease	1.62e-05	4.05e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—PTGS2—Crohn's disease	1.51e-05	3.79e-05	CbGpPWpGaD
